Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)

NACompletedINTERVENTIONAL
Enrollment

649

Participants

Timeline

Start Date

November 20, 2017

Primary Completion Date

December 23, 2020

Study Completion Date

June 30, 2021

Conditions
HIV/AIDS
Interventions
DRUG

HIV prevention package including PrEP

All MSM enrolled will benefit from a comprehensive HIV prevention package including quarterly clinical examinations, screening and treatment of STIs, screening of HIV, PrEP (TDF 300 mg + FTC 200 mg), daily or on-demand, according the participant's choice, immunisation against hepatitis B, individualised peer-led support (for adherence and prevention), group discussions, condoms, and lubricants.

Trial Locations (4)

Unknown

Centre Oasis, Association African Solidarité, Ouagadougou

Clinique de Confiance, Espace Confiance, Abidjan

Clinique des Halles, ARCAD-SIDA, Bamako

Centre Lucia, Espoir Vie Togo, Lomé

Sponsors
All Listed Sponsors
collaborator

Expertise France

OTHER

collaborator

Université Montpellier

OTHER

collaborator

SESSTIM (IRD, Inserm, Université Aix-Marseille)

UNKNOWN

collaborator

Coalition Internationale Sida

OTHER

collaborator

Institut de Médecine Tropicale, Anvers, Belgique

UNKNOWN

collaborator

ARCAD-SIDA MALI

OTHER

collaborator

Association African Solidarité

OTHER

collaborator

Centre de Recherche Internationale pour la Santé, Université de Ouagadougou

UNKNOWN

collaborator

Espace Confiance, Côte d'Ivoire

OTHER

collaborator

Espoir Vie-Togo - ONG

OTHER

collaborator

Laboratoire BIOLIM, Université de Lomé

UNKNOWN

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV